Hunter Finie, Xie Jianwu, Trimble Cameron, Bur Monica, Li King C P
Molecular Imaging Laboratory, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
Mol Cancer. 2006 Feb 3;5:5. doi: 10.1186/1476-4598-5-5.
Cancer growth, invasion and metastasis are highly related to tumor-associated neovasculature. The presence and progression of endothelial cells in cancer is chaotic, unorganized, and angiogenic vessels are less functional. Therefore, not all markers appearing on the chaotic endothelial cells are accessible if a drug is given through the vascular route. Identifying endothelial cell markers from functional cancer angiogenic vessels will indicate the accessibility and potential efficacy of vascular targeted therapies.
In order to quickly and effectively identify endothelial cell markers on the functional and accessible tumor vessels, we developed a novel technique by which tumor angiogenic vessels are labeled in vivo followed by Laser Capture Microdissection of microscopically isolated endothelial cells for genomic screening. Female C3H mice (N = 5) with established SCCVII tumors were treated with Rhodamine-RCA lectin by tail vein injection, and after fluorescence microscopy showed a successful vasculature staining, LCM was then performed on frozen section tissue using the PixCell II instrument with CapSure HS caps under the Rhodamine filter. By this approach, the fluorescent angiogenic endothelial cells were successfully picked up. As a result, the total RNA concentration increased from an average of 33.4 ng/ul +/- 24.3 (mean +/- S.D.) to 1913.4 ng/ul +/- 164. Relatively pure RNA was retrieved from both endothelial and epithelial cells as indicated by the 260/280 ratios (range 2.22-2.47). RT-PCR and gene electrophoresis successfully detected CD31 and Beta-Actin molecules with minimal Keratin 19 expression, which served as the negative control.
Our present study demonstrates that in vivo Rhodamine RCA angiogenic vessel labeling provided a practical approach to effectively guide functional endothelial cell isolation by laser capture microdissection with fluorescent microscopy, resulting in high quality RNA and pure samples of endothelial cells pooled for detecting genomic expression.
癌症的生长、侵袭和转移与肿瘤相关的新生血管密切相关。癌症中内皮细胞的存在和进展是混乱无序的,且血管生成的血管功能较差。因此,如果通过血管途径给药,并非所有出现在混乱内皮细胞上的标志物都能被药物作用到。从功能性癌症血管生成血管中识别内皮细胞标志物将表明血管靶向治疗的可及性和潜在疗效。
为了快速有效地识别功能性和可及性肿瘤血管上的内皮细胞标志物,我们开发了一种新技术,通过该技术在体内标记肿瘤血管生成血管,然后对显微镜下分离的内皮细胞进行激光捕获显微切割以进行基因组筛选。对患有已形成SCCVII肿瘤的雌性C3H小鼠(N = 5)通过尾静脉注射罗丹明-RCA凝集素进行治疗,在荧光显微镜显示血管染色成功后,使用带有CapSure HS帽的PixCell II仪器在罗丹明滤光片下对冰冻切片组织进行激光捕获显微切割。通过这种方法,成功采集到了荧光血管生成内皮细胞。结果,总RNA浓度从平均33.4 ng/ul±24.3(平均值±标准差)增加到1913.4 ng/ul±164。如260/280比率(范围2.22 - 2.47)所示,从内皮细胞和上皮细胞中均回收了相对纯净的RNA。逆转录聚合酶链反应(RT-PCR)和基因电泳成功检测到CD31和β-肌动蛋白分子,而角蛋白19表达极少,角蛋白19用作阴性对照。
我们目前的研究表明,体内罗丹明RCA血管生成血管标记为通过荧光显微镜引导激光捕获显微切割有效分离功能性内皮细胞提供了一种实用方法,从而获得了高质量的RNA和用于检测基因组表达的纯净内皮细胞样本。